EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC-ND 4.0

Comparative transcriptomics reveals a mixed basal, club, and hillock epithelial cell identity in castration-resistant prostate cancer

Samuel P Pitzen iD, Amber N Rudenick iD, Yinjie Qiu iD, Weijie Zhang iD, Sarah A Munro, Braedan M McCluskey, Colleen Forster iD, Hannah E Bergom, Atef Ali, Ella Boytim, John T Lafin iD, Simon Linder und 18 weitere

Proceedings of the National Academy of Sciences · 2025

DOI: 10.1073/pnas.2415308122 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Samuel P Pitzen und 29 weiteren Autor:innen. Beteiligte Einrichtung: Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Castration-Resistant, Epithelial Cells, Transcriptome. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: HHS | NIH | National Cancer Institute (NCI), NCI NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inhibiting the androgen receptor (AR) is effective for treatment of advanced prostate cancers because of their AR-dependent luminal epithelial cell identity. Tumors progress during therapy to castration-resistant prostate cancer (CRPC) by restoring AR signaling and maintaining luminal identity or by converting through lineage plasticity to a neuroendocrine (NE) identity or double-negative CRPC (DNPC) lacking luminal or NE identities. Here, we show that DNPC cells express genes defining basal, club, and hillock epithelial cells from benign prostate. We identified KLF5 as a regulator of genes defining this mixed basal, club, and hillock cell identity in DNPC models. KLF5-mediated upregulation of RARG uncovered a DNPC sensitivity to growth inhibition by retinoic acid receptor agonists, which down-regulated KLF5 and up-regulated AR. These findings offer CRPC classifications based on prostate epithelial cell identities and nominate KLF5 and RARG as therapeutic targets for CRPC displaying a mixed basal, club, and hillock identity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic Neoplasms, Castration-ResistantEpithelial CellsTranscriptomeMaleHumansKruppel-Like Transcription FactorsReceptors, AndrogenGene Expression Regulation, NeoplasticCell Line, TumorReceptors, Retinoic AcidGene Expression ProfilingProstate

Stichwörter der Autor:innen

KLF5castration-resistant prostate cancercell identitylineage plasticity

Substanzen

Kruppel-Like Transcription FactorsReceptors, AndrogenKLF5 protein, humanReceptors, Retinoic AcidAR protein, human

Autor:innen und Institutionen

  • Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455.
  • Graduate Program in Molecular, Cellular, and Developmental Biology and Genetics, University of Minnesota, Minneapolis, MN 55455.
  • Minnesota Supercomputing Institute, University of Minnesota, Minneapolis, MN 55455.
  • Department of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, MN 55455.
  • Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, Minneapolis, MN 55455.
  • Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN 55455.

ORCID-Profile: Samuel P Pitzen, Amber N Rudenick, Yinjie Qiu, Weijie Zhang, Colleen Forster, John T Lafin, Wout Devlies, Conner J Sessions, Frank Claessens, Eva Corey, Yuzhuo Wang, Joshua M Lang, Himisha Beltran, Douglas Strand, Emmanuel S Antonarakis, Paari Murugan, R Stephanie Huang, Scott M Dehm

Förderung

  • HHS | NIH | National Cancer Institute (NCI)
  • NCI NIH HHS
  • NIGMS NIH HHS

Zitieren

APA

Pitzen, S. P., Rudenick, A. N., Qiu, Y., Zhang, W., Munro, S. A., McCluskey, B. M., Forster, C., Bergom, H. E., Ali, A., Boytim, E., Lafin, J. T., Linder, S., Ismail, M., Devlies, W., Sessions, C. J., Claessens, F., Joniau, S., Attard, G., Zwart, W., …, & Dehm, S. M. (2025). Comparative transcriptomics reveals a mixed basal, club, and hillock epithelial cell identity in castration-resistant prostate cancer. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2415308122

Vancouver

Pitzen SP, Rudenick AN, Qiu Y, Zhang W, Munro SA, McCluskey BM, et al. Comparative transcriptomics reveals a mixed basal, club, and hillock epithelial cell identity in castration-resistant prostate cancer. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2415308122

BibTeX
@article{Pitzen2025,
  author = {Pitzen, Samuel P and Rudenick, Amber N and Qiu, Yinjie and Zhang, Weijie and Munro, Sarah A and McCluskey, Braedan M and Forster, Colleen and Bergom, Hannah E and Ali, Atef and Boytim, Ella and Lafin, John T and Linder, Simon and Ismail, Mazlina and Devlies, Wout and Sessions, Conner J and Claessens, Frank and Joniau, Steven and Attard, Gerhardt and Zwart, Wilbert and Nelson, Peter S and Corey, Eva and Wang, Yuzhuo and Lang, Joshua M and Beltran, Himisha and Strand, Douglas and Antonarakis, Emmanuel S and Hwang, Justin and Murugan, Paari and Huang, R Stephanie and Dehm, Scott M},
  title = {Comparative transcriptomics reveals a mixed basal, club, and hillock epithelial cell identity in castration-resistant prostate cancer},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  doi = {10.1073/pnas.2415308122}
}
Kostenlos starten →